Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brunner

Showing results (361-370 of 427) with videos related to

Pageof 43
Sort By:
European Journal of Heart Failure|January 18, 2020
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trialPierpaolo Pellicori, João Pedro Ferreira, Beatrice Mariottoni, et al.
Circulation. Heart Failure|November 21, 2022
Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart FailureMuhammed T Gürgöze, Laura C van Vark, Sara J Baart, et al.
European Journal of Heart Failure|August 14, 2025
Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HFJishnu Malgie, Mariëlle I Wilde, Stefan Koudstaal, et al.
JACC. Cardiovascular Imaging|June 17, 2019
Value of Speckle Tracking-Based Deformation Analysis in Screening Relatives of Patients With Asymptomatic Dilated CardiomyopathyJob A J Verdonschot, Jort J Merken, Hans-Peter Brunner-La Rocca, et al.
Journal of Cardiac Failure|December 21, 2021
The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE TrialJob A J Verdonschot, JoÃo Pedro Ferreira, Anne Pizard, et al.
European Journal of Heart Failure|December 21, 2020
Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trialMark R Hazebroek, Michiel T H M Henkens, Anne G Raafs, et al.
European Journal of Heart Failure|April 30, 2021
The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathyAnne G Raafs, Job A J Verdonschot, Michiel T H M Henkens, et al.
Journal of Biomedical Research|October 22, 2014
Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common databaseLotte Jacobs, Lutgarde Thijs, Yu Jin, et al.
European Heart Journal. Cardiovascular Imaging|October 31, 2021
The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fractionJerremy Weerts, Arantxa Barandiarán Aizpurua, Michiel T H M Henkens, et al.
European Journal of Heart Failure|May 5, 2017
Modalities and Effects of Left Ventricle Unloading on Extracorporeal Life support: a Review of the Current LiteraturePaolo Meani, Sandro Gelsomino, Eshan Natour, et al.
Pageof 43

Showing results (361-370 of 427) with videos related to

Sort By:
Pageof 43
European Journal of Heart Failure|January 18, 2020
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trialPierpaolo Pellicori, João Pedro Ferreira, Beatrice Mariottoni, et al.
Circulation. Heart Failure|November 21, 2022
Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart FailureMuhammed T Gürgöze, Laura C van Vark, Sara J Baart, et al.
European Journal of Heart Failure|August 14, 2025
Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HFJishnu Malgie, Mariëlle I Wilde, Stefan Koudstaal, et al.
JACC. Cardiovascular Imaging|June 17, 2019
Value of Speckle Tracking-Based Deformation Analysis in Screening Relatives of Patients With Asymptomatic Dilated CardiomyopathyJob A J Verdonschot, Jort J Merken, Hans-Peter Brunner-La Rocca, et al.
Journal of Cardiac Failure|December 21, 2021
The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE TrialJob A J Verdonschot, JoÃo Pedro Ferreira, Anne Pizard, et al.
European Journal of Heart Failure|December 21, 2020
Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trialMark R Hazebroek, Michiel T H M Henkens, Anne G Raafs, et al.
European Journal of Heart Failure|April 30, 2021
The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathyAnne G Raafs, Job A J Verdonschot, Michiel T H M Henkens, et al.
Journal of Biomedical Research|October 22, 2014
Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common databaseLotte Jacobs, Lutgarde Thijs, Yu Jin, et al.
European Heart Journal. Cardiovascular Imaging|October 31, 2021
The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fractionJerremy Weerts, Arantxa Barandiarán Aizpurua, Michiel T H M Henkens, et al.
European Journal of Heart Failure|May 5, 2017
Modalities and Effects of Left Ventricle Unloading on Extracorporeal Life support: a Review of the Current LiteraturePaolo Meani, Sandro Gelsomino, Eshan Natour, et al.
Pageof 43